NasdaqGS:SRPTBiotechs
Assessing Sarepta Therapeutics (SRPT) Valuation After Recent Share Price Swings
Event driven snapshot of Sarepta Therapeutics
Sarepta Therapeutics (SRPT) is back on investor radar after recent share price swings, including a 13% gain over the past week and a 19% move over the past month, against a weaker one year return.
See our latest analysis for Sarepta Therapeutics.
The recent 19.2% 30 day share price return contrasts with a weaker 1 year total shareholder return of a 68.7% decline, suggesting that short term momentum has improved while longer term holders remain...